All Posts: News Release
-
Revealing the Molecular Engine That Drives Pancreatic Cancer Provides Ways to Turn It Off
Researchers at Georgetown Lombardi have decoded a chain of molecules that are critical for the growth and survival of the most common and most lethal form of pancreatic cancer.
Category: News Release
-
Recognizing the Toll of Oral Damage From Graft-Versus-Host Disease After Stem Cell Transplant
A new state-of-the-science paper by a team of investigators including researchers from Georgetown University Medical Center concludes that too little has been done to understand and effectively treat chronic chronic graft-versus-host disease.
Category: News Release
-
Georgetown Lombardi Receives Transformational NCI Grant to Support Community Outreach and Research
Georgetown Lombardi has been selected as a member of the National Cancer Institute’s Community Oncology Research Program, a nationwide network that aims to bring cancer clinical trials and cancer care delivery studies to people living in underserved areas.
Category: News Release
-
Study Shows Why a Common Form of Immunotherapy Fails, and Suggests Solution
New research from a team led by Georgetown Lombardi’s Samir N. Khleif, MD, has uncovered a mechanism thought to explain why some cancers don’t respond to a widely used form of immunotherapy.
Category: News Release
-
Georgetown Technique Using Urine Suggests Individualized Bladder Cancer Treatment Possible
A research team, led by investigators from Georgetown University Medical Center and Fudan University in China, has devised a promising non-invasive and individualized technique for detecting and treating bladder cancer.
Category: News Release
-
Indoor Tanning May Be an Addiction Abetted by Both Genetic and Psychiatric Factors
A new study reported by researchers at Georgetown Lombardi sheds light on factors that may influence an addiction to indoor tanning in a subset of women.
Category: News Release
-
Patient Groups Untested in Cancer Immunotherapy Trials Found to Also Benefit
A study by Georgetown Lombardi Comprehensive Cancer Center physicians indicates that cancer patients with HIV or viral hepatitis, along with African Americans, who have been underrepresented in or excluded from most clinical trials, benefit from immunotherapy for cancer treatment at the same rate as other patients.
Category: News Release
-
Significant ‘Knowledge Gap’ Exists in Use of Genetic Testing to Decide Cancer Treatment
A survey aimed at assessing how well community oncologists understand “molecular profiling” results from tumor specimens found that 69 percent of participants either said they don’t know the answers, or they responded incorrectly.
Category: News Release
-
Georgetown University’s Cancer Center Receives Coveted ‘Comprehensive Cancer Center’ Status from the National Cancer Institute
WASHINGTON (May 7, 2019) — The National Cancer Institute (NCI) has renewed Georgetown Lombardi Comprehensive Cancer Center’s designation as a “comprehensive cancer center,” a distinction first awarded to Georgetown Lombardi in 1974. Of the 1,500 cancer programs in the U.S., only 50 are NCI-designated comprehensive cancer centers and Georgetown Lombardi is the only such center in the Washington, D.C., area. The […]
Category: News Release
-
Washington Women Raise $735K for Breast Cancer Research at Georgetown Lombardi
WASHINGTON (April 25, 2019) — Women & Wine, one of Washington’s largest annual philanthropic events by and for women, raised over $735K at its April 24 annual event, with proceeds designated for research and treatment at the Nina Hyde Center for Breast Cancer Research at Georgetown Lombardi Comprehensive Cancer Center. Women & Wine is one of the premier events for […]
Category: News Release